Medicaine Sting And Bite Swab
NDC Package 46414-2040-3
Package Information
Medicaine Sting And Bite (benzocaine) swabs is for temporary relief of pain and itching associated with insect bites and stings. This formulation utilizes a swab delivery system. Marketed by James Alexander Corporation, this product is identified by NDC 46414-2040 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1037117 - benzocaine 20 % / menthol 1 % Medicated Pad
- RxCUI: 1037117 - benzocaine 200 MG/ML / menthol 10 MG/ML Medicated Pad
- RxCUI: 1037117 - benzocaine 20 % / menthol 1 % Topical Swab
- RxCUI: 1094740 - Medicaine Sting and Bite 20 % / 1 % Medicated Pad
- RxCUI: 1094740 - benzocaine 200 MG/ML / menthol 10 MG/ML Medicated Pad [Medicaine Sting]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 46414 - James Alexander Corporation
- 46414-2040 - Medicaine Sting And Bite
- 46414-2040-3 - 6 mL in 1 CARTON
- 46414-2040 - Medicaine Sting And Bite
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 46414-2040-3 identifies a specific commercial package of 6 ml in 1 carton of Medicaine Sting And Bite, a human over the counter drug labeled by James Alexander Corporation. This swab is formulated for topical use and contains benzocaine; menthol, unspecified form as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by James Alexander Corporation on November 15, 1986. The current certification is valid through December 31, 2026.
How is this James Alexander Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 46414204003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.